2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

نویسندگان

  • Bhaskar Dasgupta
  • Marco A Cimmino
  • Hilal Maradit-Kremers
  • Wolfgang A Schmidt
  • Michael Schirmer
  • Carlo Salvarani
  • Artur Bachta
  • Christian Dejaco
  • Christina Duftner
  • Hanne Slott Jensen
  • Pierre Duhaut
  • Gyula Poór
  • Novák Pál Kaposi
  • Peter Mandl
  • Peter V Balint
  • Zsuzsa Schmidt
  • Annamaria Iagnocco
  • Carlotta Nannini
  • Fabrizio Cantini
  • Pierluigi Macchioni
  • Nicolò Pipitone
  • Montserrat Del Amo
  • Georgina Espígol-Frigolé
  • Maria C Cid
  • Víctor M Martínez-Taboada
  • Elisabeth Nordborg
  • Haner Direskeneli
  • Sibel Zehra Aydin
  • Khalid Ahmed
  • Brian Hazleman
  • Barbara Silverman
  • Colin Pease
  • Richard J Wakefield
  • Raashid Luqmani
  • Andy Abril
  • Clement J Michet
  • Ralph Marcus
  • Neil J Gonter
  • Mehrdad Maz
  • Rickey E Carter
  • Cynthia S Crowson
  • Eric L Matteson
چکیده

The objective of this study was to develop EULAR/ACR classification criteria for polymyalgia rheumatica (PMR). Candidate criteria were evaluated in a 6-month prospective cohort study of 125 patients with new onset PMR and 169 non-PMR comparison subjects with conditions mimicking PMR. A scoring algorithm was developed based on morning stiffness >45 minutes (2 points), hip pain/limited range of motion (1 point), absence of RF and/or ACPA (2 points), and absence of peripheral joint pain (1 point). A score ≥4 had 68% sensitivity and 78% specificity for discriminating all comparison subjects from PMR. The specificity was higher (88%) for discriminating shoulder conditions from PMR and lower (65%) for discriminating RA from PMR. Adding ultrasound, a score ≥5 had increased sensitivity to 66% and specificity to 81%. According to these provisional classification criteria, patients ≥50 years old presenting with bilateral shoulder pain, not better explained by an alternative pathology, can be classified as having PMR in the presence of morning stiffness>45 minutes, elevated CRP and/or ESR and new hip pain. These criteria are not meant for diagnostic purposes.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Polymyalgia rheumatica - ClinicalKey

Polymyalgia rheumatica is a chronic, inflammatory disorder of unknown cause that affects people over age 50 years. Classic symptoms include pain and long-term morning stiffness of the neck, shoulders, hips, upper arms, and thighs. Although markers of inflammation are often raised, no specific laboratory test exists for the disorder and the diagnosis is based on clinical assessment. Provisional ...

متن کامل

Role of ultrasonography in the diagnosis of rheumatic diseases in light of ACR/EULAR guidelines

In the past years, ultrasound imaging has become an integral element of the diagnostic process in rheumatic diseases. It enables the identification of a range of inflammatory changes in joint cavities, sheaths and bursae, and allows their activity to be assessed. In 2012, experts of the European Society of Musculoskeletal Radiology prepared recommendations concerning the role of ultrasonography...

متن کامل

CLINICAL CASE Tocilizumab is effective against polymyalgia rheumatica: experience in 13 intractable cases

Correspondence to Dr Keisuke Izumi; [email protected] ABSTRACT Polymyalgia rheumatica (PMR) affects older people, and although glucocorticoids are effective in treating PMR, they frequently result in side effects. Therefore, we conducted a retrospective study to assess the effectiveness and safety of tocilizumab as an alternative to glucocorticoids. We included 13 consecutive patients with PMR (11 wo...

متن کامل

Tocilizumab is effective against polymyalgia rheumatica: experience in 13 intractable cases

Polymyalgia rheumatica (PMR) affects older people, and although glucocorticoids are effective in treating PMR, they frequently result in side effects. Therefore, we conducted a retrospective study to assess the effectiveness and safety of tocilizumab as an alternative to glucocorticoids. We included 13 consecutive patients with PMR (11 women and 2 men; median age, 74 years) diagnosed according ...

متن کامل

2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

Therapy for polymyalgia rheumatica (PMR) varies widely in clinical practice as international recommendations for PMR treatment are not currently available. In this paper, we report the 2015 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) recommendations for the management of PMR. We used the Grading of Recommendations, Assessment, Development and Evaluation (GR...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 71  شماره 

صفحات  -

تاریخ انتشار 2012